IHLD MedTech receives investment of $3 million
As India grapples with a growing burden of diabetes and chronic wounds, a network of specialised wound-care Centres of Excellence is set to be rolled out across the country over the next two to three years, offering integrated diagnosis, treatment and long-term monitoring for patients with chronic and non-healing wounds.
The centres are being developed under the Wound Heal Plus initiative of IHLD MedTech, which has received an initial investment tranche of US$3 million from Singapore-listed Ultra-Green.ai, with the potential for additional investments that could increase the total investment to up to US$12 million, subject to mutually agreed milestones and other agreed conditions. The funding will support the expansion of IHLD MedTech’s Wound Heal Plus and iLiveConnect platforms.
IHLD MedTech, an Indian medtech company building technology-led healthcare delivery platforms, said the centres would bring together wound screening, advanced imaging, treatment, rehabilitation and digital follow-up services under one roof, addressing what experts describe as a major but often neglected area of healthcare.
The investment will also support the expansion of iLiveConnect, a doctor-led, AI-enabled continuity-care platform designed to extend healthcare far beyond hospital walls. “One of the biggest challenges in India, and indeed across the world, is that wound care remains a largely neglected area of healthcare,” Dr Rahul Chandola, cardiovascular surgeon and Founder and Managing Director of IHLD MedTech, said.
The Wound Heal Plus centres will offer a multidisciplinary approach involving vascular surgeons, plastic surgeons, podiatrists, orthotists, nutritionists, physiotherapists and rehabilitation specialists.
“We believe the future of healthcare lies at the intersection of advanced technology, clinical intelligence and continuous patient engagement,” said Ravinder Sajwan, CEO of UltraGreen.ai.
A key feature of the programme is the use of advanced fluorescence imaging technology that allows clinicians to assess blood flow and tissue perfusion within wounds.
The resulting images are analysed through WoundLinks, a software platform developed in collaboration with UltraGreen.ai, helping doctors identify poorly perfused tissue and make more precise treatment decisions, Dr Chandola said.
Beyond hospital-based treatment, patients will continue to receive care through iLiveConnect’s continuity-care platform and mobile wound-care clinics after discharge, enabling specialists to track healing, identify risks early and intervene when necessary.
